211 related articles for article (PubMed ID: 32149872)
1. Adherence to the National Comprehensive Cancer Network Criteria of Complete Circumferential Peripheral and Deep Margin Assessment in Treatment of High-Risk Basal and Squamous Cell Carcinoma.
Danesh MJ; Menge TD; Helliwell L; Mahalingam M; Waldman A
Dermatol Surg; 2020 Dec; 46(12):1473-1480. PubMed ID: 32149872
[TBL] [Abstract][Full Text] [Related]
2. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
3. British Association of Dermatologists (BAD) National Audit on Non-Melanoma Skin Cancer Excision 2016 in collaboration with the Royal College of Pathologists.
Keith DJ; Bray AP; Brain A; Mohd Mustapa MF; Barrett HE; Lane S; Emmerich M; Jakes A; Barrett PD; de Berker DAR
Clin Exp Dermatol; 2020 Jan; 45(1):48-55. PubMed ID: 31265150
[TBL] [Abstract][Full Text] [Related]
4. Patterns of care for anal cancer in the United States - a comparison between academic and community cancer centers.
Pricolo VE; Bonvini M; Abelli CF
BMC Cancer; 2018 May; 18(1):567. PubMed ID: 29769057
[TBL] [Abstract][Full Text] [Related]
5. The art and science of surgical margins for the dermatopathologist.
Weinstein MC; Brodell RT; Bordeaux J; Honda K
Am J Dermatopathol; 2012 Oct; 34(7):737-45. PubMed ID: 23000878
[TBL] [Abstract][Full Text] [Related]
6. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
7. The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
Siscos SM; Neill BC; Seger EW; Hooton TA; Hocker TLH
Dermatol Surg; 2020 Oct; 46(10):1267-1271. PubMed ID: 32740213
[TBL] [Abstract][Full Text] [Related]
8. Negative Predictive Value of Biopsy Margins in Keratinocyte Carcinoma: A Literature Review.
Purnell JC; Duncan JR; Stratton MS; Huang C; Phillips CB
Dermatol Surg; 2020 Apr; 46(4):525-529. PubMed ID: 31567613
[TBL] [Abstract][Full Text] [Related]
9. Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?
Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
[TBL] [Abstract][Full Text] [Related]
10. Practice habits of Mohs surgeons treating melanoma with Mohs surgery: A cross-sectional survey.
Siscos SM; Neill BC; Seger EW; Rajpara A; Hocker TLH
J Am Acad Dermatol; 2021 Mar; 84(3):833-835. PubMed ID: 33022309
[No Abstract] [Full Text] [Related]
11. The compliance of plastic surgeons in the UK with the national guidelines for primary cutaneous squamous cell carcinoma.
Soueid A; Oudit D; Paterson P
J Plast Reconstr Aesthet Surg; 2009 Nov; 62(11):e500-2. PubMed ID: 18804425
[No Abstract] [Full Text] [Related]
12. Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment.
Firnhaber JM
Am Fam Physician; 2020 Sep; 102(6):339-346. PubMed ID: 32931212
[TBL] [Abstract][Full Text] [Related]
13. Local Recurrence Rates of Skin Tumors After Resection With Complete Circumferential Peripheral and Deep Margin Assessment-Identification of High-Risk Entities.
Kofler L; Breuninger H; Schulz C; Häfner HM; Kofler K
Dermatol Surg; 2021 Feb; 47(2):e31-e36. PubMed ID: 33565775
[TBL] [Abstract][Full Text] [Related]
14. Upstaging of basal cell and squamous cell carcinomas during definitive surgery: a review of predictive preoperative clinical and histologic features.
Clements S; Khachemoune A
Arch Dermatol Res; 2021 Jul; 313(5):319-325. PubMed ID: 33108525
[TBL] [Abstract][Full Text] [Related]
15. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
16. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.
Schell AE; Russell MA; Park SS
JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451
[TBL] [Abstract][Full Text] [Related]
17. Exploring knowledge gaps in the understanding of peripheral and deep en face margin assessment.
Sable KA; Rudningen KE; Lasarev MR; Xu YG
Arch Dermatol Res; 2023 Nov; 315(9):2683-2687. PubMed ID: 37222796
[TBL] [Abstract][Full Text] [Related]
18. Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee.
Leitenberger JJ; Rogers H; Chapman JC; Maher IA; Fox MC; Harmon CB; Bailey EC; Odland P; Wysong A; Johnson T; Wisco OJ
J Am Acad Dermatol; 2016 Nov; 75(5):1022-1031. PubMed ID: 27546292
[TBL] [Abstract][Full Text] [Related]
19. Variation among pathologists' treatment suggestions for melanocytic lesions: A survey of pathologists.
Lee KC; Peacock S; Weinstock MA; Zhao GA; Knezevich SR; Elder DE; Barnhill RL; Piepkorn MW; Reisch LM; Carney PA; Onega T; Lott JP; Elmore JG
J Am Acad Dermatol; 2017 Jan; 76(1):121-128. PubMed ID: 27692732
[TBL] [Abstract][Full Text] [Related]
20. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
